ERBB2 and breast cancer: PIK3CA‐H1047R mammary tumors showed strong activation of phosphorylated AKT, phosphorylated Gsk3‐β, cyclin D1, and activated β‐catenin compared to tumors from Her‐2 transgenic mice (Fig. 2A).